Skip to content

Alcohol Treatment Using a Smartphone Application for Patients with Alcohol Use Disorder

Alcohol treatment using a smartphone application for patients with alcohol use disorder.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011460
Enrollment
200
Registered
2026-01-14
Start date
2022-11-25
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : This study's intervention involves the use of a smartphone application based on cognitive-behavioral therapy (CBT), aiming to evaluate its effects on alcohol abstinence maintenance and re

Sponsors

Hallym University Medical Center- Chuncheon
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Selection Criteria for Participants a) Adults aged 19 or older b) Individuals who meet the diagnostic criteria for Alcohol Use Disorder in DSM-5 and have been diagnosed with mental and behavioral disorders due to alcohol use (F10) according to ICD-10 c) Individuals who have no difficulty reading and writing in Korean d) Individuals who are able to use mobile applications on universal devices (such as smartphones or tablets) without difficulty e) Individuals who, after receiving sufficient explanation and understanding of the clinical trial, voluntarily decide to participate and agree in writing to comply with the precautions f) Individuals who are not diagnosed with dementia according to the judgment of a clinical doctor g) Individuals who, after receiving a detailed explanation about the study and fully understanding it, voluntarily decide to participate in the research and provide written consent, or their legal representatives do so Note: Additional selection criteria may be included depending on the features and target population of the developed smartphone application therapeutic device.

Exclusion criteria

Exclusion criteria: a) Any advanced, severe, progressive, or unstable disease that could put the patient at risk b) Any medical or other neurological conditions that could explain cognitive decline (e.g., abnormal thyroid function tests, vitamin B12 or folate deficiency, post-traumatic conditions, Huntington's disease, multiple sclerosis, cerebral palsy, encephalitis, meningitis, or any diseases affecting the central nervous system) c) Any other primary neurodegenerative dementias, excluding depression, schizophrenia, or bipolar disorder, including all other DSM-V Axis I diagnoses d) Individuals currently having uncontrolled seizure disorders e) Individuals with a history of brain injury resulting in a loss of consciousness for more than 1 hour or hospitalization within the past 3 years f) Hearing or vision impairments that may interfere with the performance of the required tasks in the clinical trial g) Individuals deemed unsuitable for the study according to the judgment of the investigator

Design outcomes

Primary

MeasureTime frame
Maintenance of Abstinence for 9 to 12 weeks

Secondary

MeasureTime frame
AUDIT-K Scores;AUQ-K Scores;CIWA-Ar Scores;HADS Scores;CRQ Scores;HAIS Scores;K-BADS Scores;SOCRATES-K Scores;K-MAAS Scores

Countries

Korea, Republic of

Contacts

Public ContactSong-Hee Lim

Hallym University Medical Center- Chuncheon

ka121796@gmail.com+82-33-240-5000

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026